Management of Incidentally Discovered Complex Renal Cysts

Initial Imaging Characterization

Obtain a multiphase contrast‑enhanced CT or MRI as the first imaging study to classify incidentally found complex renal cysts using the 2019 Bosniak system. 1
When CT is equivocal or iodinated contrast is contraindicated, gadolinium‑enhanced MRI provides higher specificity (≈68 % vs 27 % for CT) while maintaining comparable sensitivity for detecting malignancy. 2

Bosniak I/II lesions carry a low malignancy risk (0–15.6 %) and do not require routine radiologic follow‑up. 1
Bosniak IIF lesions have a 10.9–25 % chance of progression to malignancy; they should be referred to urology for a surveillance plan. 1
Bosniak III lesions demonstrate a 40–54 % malignancy rate, but because only about 51 % are malignant and most have low malignant potential, active surveillance is an acceptable alternative to immediate surgery. 1
Bosniak IV lesions have an 84–90 % likelihood of being malignant and warrant urgent urologic referral for definitive intervention. [1][3]

Core‑needle biopsy performed with a coaxial technique yields a diagnostic result in 78–97 % of cases and has a low complication rate (~0.9 %). [1][2]
Biopsy is recommended for:
A nondiagnostic biopsy should not be interpreted as evidence of benign disease; repeat biopsy or surgical excision should be considered. [2][3]

For Bosniak III cysts and small solid masses (<4 cm), active surveillance is endorsed as a safe alternative to immediate surgery, given the modest malignancy rate and generally indolent behavior. [1][4]
Surveillance protocol:

Any enhancing solid renal mass (≥10–15 HU on CT or ≥15 % enhancement on MRI). 1
Bosniak IIF, III, or IV lesions (for surveillance planning, discussion of management options, or urgent intervention respectively). 1

Order baseline laboratory studies: comprehensive metabolic panel, complete blood count, and urinalysis. 5
Perform a chest CT to screen for pulmonary metastases, the most common distant site for renal cell carcinoma. 5
Stage chronic kidney disease using estimated GFR and proteinuria assessment. 5
Routine bone or brain imaging is not required for localized disease unless clinically indicated by symptoms. 1

The American College of Radiology recommends that homogeneous masses <20 HU on unenhanced CT are benign simple cysts and require no further evaluation or referral 6, 7
Homogeneous masses >70 HU on unenhanced CT are benign and require no further evaluation or referral, according to the American College of Radiology 6, 7
The American College of Radiology suggests that homogeneous cysts measuring 10-20 HU on contrast-enhanced CT are benign and require no referral 7
Multiphase CT with and without IV contrast is the primary imaging modality for characterizing indeterminate renal masses, with diagnostic accuracy of 79.4% for predicting renal cell carcinoma, as recommended by the American College of Radiology 8
MRI with gadolinium-based contrast offers superior specificity and is particularly useful for complex cystic lesions and when CT findings are equivocal, according to the American College of Radiology 8, 9
Contrast-enhanced ultrasound (CEUS) is valuable when iodinated CT contrast or gadolinium-based MRI contrast is contraindicated, with accuracy of 90.2% for characterizing indeterminate lesions, as suggested by the American College of Radiology 10

The American College of Radiology recommends referring to urology when any enhancing solid mass (>10-15 HU enhancement on CT or >15% enhancement on MRI) is present 8, 9
Masses containing macroscopic fat are typically benign angiomyolipomas, but lipid-poor angiomyolipomas cannot be differentiated from renal cell carcinoma on imaging alone and may require biopsy, according to the American College of Radiology 8, 9
Bosniak IIF lesions have a 10.9-25% progression rate to malignancy and require urologic consultation for surveillance planning, as recommended by the American College of Radiology 8
Bosniak III lesions have a 40-54% malignancy rate and require urologic evaluation, according to the American College of Radiology 8
Bosniak IV lesions have a 90% malignancy rate and require urgent urologic referral, as suggested by the American College of Radiology 8

Renal mass biopsy is not the initial workup but has expanded indications, including small renal masses (T1a, <4 cm), suspected benign tumors, and patients with limited life expectancy or significant comorbidities, according to the American College of Radiology 6, 10
Active surveillance has become an accepted management option for small renal masses (<4 cm), as many demonstrate slow growth kinetics with low progression rates, as recommended by the American College of Radiology 6, 10

The American College of Radiology defines homogeneous renal masses with attenuation > 70 HU on non‑contrast CT as benign hyperdense cysts that require no further imaging, urologic referral, or surveillance. 11
Lesions measuring 20–70 HU on non‑contrast CT are considered indeterminate and should be evaluated with multiphase contrast‑enhanced CT or MRI for definitive characterization. 11

Gadolinium‑enhanced MRI provides substantially higher specificity for detecting solid components in complex cystic renal lesions (≈ 68 % vs 27 % for CT), making it the preferred modality when CT findings are equivocal. 11
Unenhanced MRI, particularly T2‑weighted sequences, offers superior ability to identify simple cysts by their homogeneous high signal intensity compared with unenhanced CT. 11

For Bosniak III lesions where the balance between immediate treatment and observation is unclear—especially in patients with limited life expectancy or significant comorbidities—the American College of Radiology recommends percutaneous biopsy to aid decision‑making. 11
Biopsy is also advised for renal masses < 4 cm when histologic results would influence the choice between active surveillance and definitive intervention. 11
A nondiagnostic biopsy should not be taken as proof of benignity; repeat biopsy or surgical excision should be pursued to obtain a definitive diagnosis. 11